These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

511 related items for PubMed ID: 21885318

  • 1. [Targeted therapies and radiation therapy in non-small cell lung cancer].
    Rivera S, Quéro L, Wong Hee Kam S, Maylin C, Deutsch E, Hennequin C.
    Cancer Radiother; 2011 Oct; 15(6-7):527-35. PubMed ID: 21885318
    [Abstract] [Full Text] [Related]

  • 2. Directed therapies in lung cancer: new hope?
    Parente Lamelas I, Abal Arca J, Fírvida Pérez JL.
    Arch Bronconeumol; 2012 Oct; 48(10):367-71. PubMed ID: 22551924
    [Abstract] [Full Text] [Related]

  • 3. Potential role for epidermal growth factor receptor inhibitors in combined-modality therapy for non-small-cell lung cancer.
    Kim DW, Choy H.
    Int J Radiat Oncol Biol Phys; 2004 Oct; 59(2 Suppl):11-20. PubMed ID: 15142630
    [Abstract] [Full Text] [Related]

  • 4. [Radiotherapy and targeted therapies in head and neck carcinomas and NSCLC].
    Bruna A, Bourhis J.
    Bull Cancer; 2009 Oct; 96 Suppl 1():65-8. PubMed ID: 19433375
    [Abstract] [Full Text] [Related]

  • 5. Targeted agents in non-small cell lung cancer (NSCLC): clinical developments and rationale for the combination with thoracic radiotherapy.
    Koh PK, Faivre-Finn C, Blackhall FH, De Ruysscher D.
    Cancer Treat Rev; 2012 Oct; 38(6):626-40. PubMed ID: 22196919
    [Abstract] [Full Text] [Related]

  • 6. New molecular targeted therapies integrated with radiation therapy in lung cancer.
    Provencio M, Sánchez A, Garrido P, Valcárcel F.
    Clin Lung Cancer; 2010 Mar 01; 11(2):91-7. PubMed ID: 20199974
    [Abstract] [Full Text] [Related]

  • 7. New targets for non-small-cell lung cancer therapy.
    Alvarez M, Roman E, Santos ES, Raez LE.
    Expert Rev Anticancer Ther; 2007 Oct 01; 7(10):1423-37. PubMed ID: 17944567
    [Abstract] [Full Text] [Related]

  • 8. Targeted therapies for non-small-cell lung cancer: biology, rationale, and preclinical results from a radiation oncology perspective.
    Raben D, Helfrich B, Bunn PA.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 59(2 Suppl):27-38. PubMed ID: 15142632
    [Abstract] [Full Text] [Related]

  • 9. Targeted therapy in non-small-cell lung cancer.
    Herbst RS.
    Oncology (Williston Park); 2002 Sep 01; 16(9 Suppl 9):19-24. PubMed ID: 12375797
    [Abstract] [Full Text] [Related]

  • 10. Recent developments of targeted therapies in the treatment of non-small cell lung cancer.
    Rossi A, Maione P, Colantuoni G, Ferrara C, Rossi E, Guerriero C, Nicolella D, Falanga M, Palazzolo G, Gridelli C.
    Curr Drug Discov Technol; 2009 Jun 01; 6(2):91-102. PubMed ID: 19519336
    [Abstract] [Full Text] [Related]

  • 11. [Targeted therapies in the treatment of non-small cell lung cancer].
    De Grève J, Decoster L, Van Meerbeek J, Vermeij J, Teugels E, Schallier D.
    Bull Cancer; 2008 Mar 01; 95(3):358-64. PubMed ID: 18390417
    [Abstract] [Full Text] [Related]

  • 12. Multitargeted inhibitors in lung cancer: new clinical data.
    Bar J, Herbst RS, Onn A.
    Clin Lung Cancer; 2008 Mar 01; 9 Suppl 3():S92-9. PubMed ID: 19419930
    [Abstract] [Full Text] [Related]

  • 13. [New therapies for the treatment of advanced non-small cell lung cancer: inhibitors of the epidermal growth factor receptor and angiogenesis].
    Lind JS, Herder GJ, Smit EF.
    Ned Tijdschr Geneeskd; 2008 Apr 19; 152(16):928-32. PubMed ID: 18561788
    [Abstract] [Full Text] [Related]

  • 14. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR, Zbuk K.
    Clin Ther; 2013 Sep 19; 35(9):1282-303. PubMed ID: 24054705
    [Abstract] [Full Text] [Related]

  • 15. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
    Maione P, Gridelli C, Troiani T, Ciardiello F.
    Oncologist; 2006 Mar 19; 11(3):274-84. PubMed ID: 16549812
    [Abstract] [Full Text] [Related]

  • 16. Targeted therapies in the treatment of advanced non-small-cell lung cancer: update.
    Mendoza L.
    Klin Onkol; 2009 Mar 19; 22(4):131-8. PubMed ID: 19731875
    [Abstract] [Full Text] [Related]

  • 17. Emerging role of epidermal growth factor receptor inhibition in therapy for advanced malignancy: focus on NSCLC.
    Langer CJ.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):991-1002. PubMed ID: 14967461
    [Abstract] [Full Text] [Related]

  • 18. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
    Raben D, Helfrich B, Chan DC, Ciardiello F, Zhao L, Franklin W, Barón AE, Zeng C, Johnson TK, Bunn PA.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 1):795-805. PubMed ID: 15701870
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy and antiangiogenic agents in non-small-cell lung cancer.
    Horn L, Sandler A.
    Clin Lung Cancer; 2007 Feb 15; 8 Suppl 2():S68-73. PubMed ID: 17382027
    [Abstract] [Full Text] [Related]

  • 20. The emerging role of vascular endothelial growth factor receptor tyrosine kinase inhibitors.
    Langer CJ, Natale RB.
    Semin Oncol; 2005 Dec 15; 32(6 Suppl 10):S23-9. PubMed ID: 16459176
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.